🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 01/05/2023 | 115,80 | 116,60 | 115,27 | 116,34 | +0,75% | 1,15% | 5.238.900 |
| 28/04/2023 | 114,36 | 115,53 | 113,46 | 115,47 | +0,27% | 1,81% | 8.050.400 |
| 27/04/2023 | 114,60 | 115,36 | 110,66 | 115,16 | +1,53% | 4,10% | 9.975.200 |
| 26/04/2023 | 115,20 | 115,20 | 112,72 | 113,43 | -2,66% | 2,15% | 6.607.900 |
| 25/04/2023 | 116,22 | 116,86 | 115,91 | 116,53 | +0,51% | 0,82% | 5.662.800 |
| 24/04/2023 | 115,64 | 116,28 | 114,77 | 115,94 | +0,49% | 1,31% | 4.299.100 |
| 21/04/2023 | 114,87 | 115,65 | 114,59 | 115,37 | +1,05% | 0,92% | 6.554.600 |
| 20/04/2023 | 114,18 | 114,52 | 113,00 | 114,17 | +0,04% | 1,33% | 4.657.900 |
| 19/04/2023 | 114,49 | 115,39 | 114,01 | 114,13 | -0,61% | 1,21% | 4.683.400 |
| 18/04/2023 | 114,48 | 115,12 | 113,73 | 114,83 | -0,16% | 1,21% | 5.454.500 |
| 17/04/2023 | 115,69 | 116,45 | 114,20 | 115,01 | -0,26% | 1,94% | 6.575.500 |
| 14/04/2023 | 115,74 | 116,17 | 114,66 | 115,31 | -0,23% | 1,30% | 5.005.100 |
| 13/04/2023 | 114,97 | 115,82 | 113,65 | 115,58 | +1,61% | 1,89% | 7.332.300 |
| 12/04/2023 | 112,25 | 114,31 | 111,88 | 113,75 | +1,12% | 2,16% | 6.136.700 |
| 11/04/2023 | 112,72 | 113,31 | 112,32 | 112,49 | -0,11% | 0,88% | 5.639.800 |
| 10/04/2023 | 112,96 | 113,09 | 111,17 | 112,61 | +0,25% | 1,70% | 6.446.500 |
| 06/04/2023 | 113,00 | 114,17 | 111,64 | 112,33 | +0,38% | 2,24% | 6.894.500 |
| 05/04/2023 | 109,91 | 112,34 | 109,58 | 111,91 | +2,83% | 2,51% | 8.006.100 |
| 04/04/2023 | 108,70 | 109,34 | 108,16 | 108,83 | -0,04% | 1,09% | 6.108.200 |
| 03/04/2023 | 105,95 | 109,48 | 105,57 | 108,87 | +2,33% | 3,69% | 6.964.100 |
| 31/03/2023 | 106,23 | 106,53 | 105,52 | 106,39 | +0,44% | 0,95% | 7.184.300 |
| 30/03/2023 | 105,12 | 106,20 | 104,54 | 105,92 | +0,95% | 1,58% | 5.017.400 |
| 29/03/2023 | 105,62 | 105,87 | 104,53 | 104,92 | -0,58% | 1,27% | 6.310.200 |
| 28/03/2023 | 106,61 | 107,03 | 105,44 | 105,53 | -1,31% | 1,49% | 6.679.500 |
| 27/03/2023 | 106,08 | 107,61 | 105,99 | 106,93 | +2,03% | 1,53% | 7.563.100 |
| 24/03/2023 | 104,09 | 105,01 | 102,44 | 104,80 | +0,55% | 2,47% | 6.661.800 |
| 23/03/2023 | 104,10 | 104,63 | 103,46 | 104,23 | -0,16% | 1,12% | 6.801.700 |
| 22/03/2023 | 105,47 | 106,00 | 104,39 | 104,40 | -1,08% | 1,53% | 5.705.800 |
| 21/03/2023 | 106,00 | 106,43 | 104,76 | 105,54 | -0,29% | 1,58% | 11.571.800 |
| 20/03/2023 | 104,82 | 106,91 | 104,82 | 105,85 | +1,68% | 1,99% | 12.865.800 |